inTEST Corporation (INTT) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals mixed signals: strong order growth in key sectors and successful diversification efforts are positive, but revenue and gross profit declines, limited market recovery visibility, and flat guidance despite resolved challenges are concerning. The Q&A section highlights management's confidence, yet lacks clarity on guidance adjustments. Market conditions remain weak, especially in the semi sector, and margin declines further temper optimism. Overall, the sentiment remains neutral as positive long-term fundamentals balance short-term uncertainties and financial performance issues.
Key Financial Performance
Orders $37.6 million, up 34.2% year-over-year. The increase reflects strength in auto/EV (up $7.4 million), industrial (up $2.4 million), defense/aerospace (up $1.9 million), life sciences (up $0.9 million), and semi (up $0.4 million). Reasons include strong demand for test equipment, market diversification, and adoption of new products.
Revenue $26.2 million, down $4 million year-over-year. The decline reflects lower sales in semi, auto/EV, defense/aerospace, and other markets totaling $5 million, partially offset by increases in life sciences and safety/security totaling $1 million. Reasons include technical challenges delaying shipments and reduced volume.
Gross Profit $11 million, down $3 million year-over-year. Gross margin declined 440 basis points to 41.9%. Reasons include reduced volume and unfavorable product mix.
Operating Expenses $12.2 million, down $1.3 million year-over-year. Reasons include cost reduction actions and consolidation of the Videology Netherlands facility, which is expected to save $500,000 annually starting in 2026.
Net Loss $0.9 million or $0.08 per share. Adjusted net loss was $0.02 per share. Reasons include lower revenue and gross profit.
Adjusted EBITDA $0.4 million. Reasons include lower revenue and gross profit.
Debt Reduction $6.2 million reduced in the first 9 months of 2025, including $1.2 million in Q3. Total debt outstanding was $8.9 million at quarter end. Reasons include financial management and cash generation.
Cash and Liquidity Cash, cash equivalents, and restricted cash were $21.1 million, up $1.8 million from Q2. Total liquidity was approximately $61 million. Reasons include cash generation and financial management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Acculogic's flying probe capabilities: Expanded to include radio frequency and oscilloscope measurement test solutions, enhancing manufacturing efficiencies.
New test equipment: Innovative and differentiated equipment for automotive and defense/aerospace markets, enabling better quality control in complex manufacturing processes.
Automotive/EV market: Orders doubled to $14.6 million, driven by demand from Tier 1 electronic suppliers for 2027 model year programs.
Defense/aerospace market: Orders more than doubled to $6.4 million due to increased test demand for next-generation weapon systems.
Revenue challenges: Q3 revenue was $26.2 million, below Q2 and guidance due to technical challenges delaying $2 million in shipments.
Cost reduction: Consolidation of Videology Netherlands facility expected to save $500,000 annually starting in 2026.
Debt reduction: Reduced debt by $6.2 million in the first 9 months of 2025, with $8.9 million total debt outstanding.
VISION 2030 strategy: Focus on market diversification, penetrating new accounts, expanding manufacturing footprint, and introducing value-driven products.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Order sluggishness and economic uncertainties: Customers' capital investment plans have been complicated by tariff and economic uncertainties, leading to sluggish order rates in some markets.
Technical challenges in system finalization: Engineers faced technical challenges in finalizing systems, delaying approximately $2 million in shipments. These challenges were linked to new capabilities and new customer requirements.
Hesitancy in capital project commitments: Many customers, particularly in the semiconductor market, remain hesitant to commit to new capital projects, impacting revenue and growth.
Decline in revenue and gross profit: Revenue for Q3 was $26.2 million, a decrease from the previous quarter and year-over-year, driven by lower sales in key markets such as defense/aerospace, auto/EV, and semi.
Unfavorable product mix and reduced volume: Gross margin declined due to reduced sales volume and an unfavorable product mix, despite efforts to mitigate tariff impacts.
Limited visibility into market recovery: The company lacks visibility into the timing of an overall market recovery, creating uncertainty in forecasting and planning.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Market Recovery: The company anticipates a gradual market recovery, with some pockets of renewed capital spending observed, particularly in the automotive and defense/aerospace sectors. However, visibility into the timing of a full market recovery remains limited.
Revenue Guidance for Q4 2025: Revenue is expected to rebound to a range of $30 million to $32 million in the fourth quarter of 2025, including shipments delayed from Q3.
Gross Margin Guidance for Q4 2025: Gross margin is forecasted to be approximately 43% in the fourth quarter of 2025.
Operating Expenses for Q4 2025: Operating expenses are projected to range between $12.3 million and $12.7 million, excluding approximately $200,000 of restructuring expenses.
Backlog and Future Demand: The backlog at the end of Q3 2025 was $49.3 million, with more than half scheduled to ship in 2026. This backlog and a strong funnel of opportunities suggest improving demand in some end markets.
Product and Market Strategy: The company is focusing on penetrating new target accounts, broadening channel networks, and expanding its manufacturing footprint to support global customer needs. New product introductions are expected to deliver more value to customers and position the company for growth.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you break out the $2 million pushouts into specific verticals?
A:$1.5 million was tied to the life science markets, specifically to systems at the Alfamation business for medical technology. The challenges were resolved, and the tools have been shipped. The remaining amount was tied to the semi industry at Acculogic, where one tool shipment was delayed by a week.
Q:How long can we expect strong automotive orders to continue?
A:The strong automotive orders tied to 2027 model years started last quarter and are expected to continue for the foreseeable future. The funnel remains healthy with new opportunities, driven by investments in new technologies like infotainment, CCUs, displays, and lighting.
Q:Were the challenges in the quarter a continuation of those from the first quarter?
A:No, the challenges were different. The first quarter issues were repetitive challenges at ITS thermal solutions, which required changes. The current quarter's challenges were tied to new technologies at Alfamation and Acculogic, which caused delays but were resolved, leading to customer satisfaction and future growth opportunities.
Q:What are you seeing in the semi market, particularly in the front-end and back-end?
A:The front-end market activity remains anemic, with some signs of life and optimism for the future (2026-2027). The back-end market is softer, with larger customers facing tariff issues and investment challenges, particularly in China. Analog mixed signal markets show similar trends.
Q:Why is the fourth-quarter guidance not higher despite the $2 million revenue shift from Q3?
A:The $2 million revenue shift was tied to new technologies, which took longer to implement but are now resolved. The guidance reflects minimal risk and confidence in achieving the forecast. Strong Q3 orders are for delivery in Q1 2026 and beyond, contributing to the guidance.
Q:What is happening within the industrial segment?
A:The industrial segment is stable but has delayed projects due to customers holding back on CapEx. The company is capturing available opportunities, and the segment is expected to improve as the economy recovers.
Q:What is the outlook for the company's diversification efforts?
A:The diversification into defense/aero, automotive, and life sciences is paying off, with robust activities and orders in these areas. Semi and industrial markets are expected to recover, positioning the company well for future growth.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing whether the fourth-quarter guidance reflects a potential slowdown or tightening of expectations. While they emphasized confidence in the forecast and positive order activity, they did not provide a clear explanation for why the guidance appears flat despite the $2 million revenue shift from Q3.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Acculogic probe
Alfamation booking
Cash cash
Commission presentation
Conference Instructions
Defense aerospace
EV climb
EV defense
EV semi
Instructions conference
Results Conference
Sales defense
Slide auto
Slide comparison
Slide decrease
VISION goal
auto EV
capability
capacity
capital project
case
challenge system
conversion rate
defense aerospace
end market
goal Slide
inTEST
increase life
loss share
market recovery
month
pocket capital
point volume
safety security
science safety
security market
success
test equipment
INTT Transcript
InTest Corporation (INTT) Q1 2026 Earnings Call Transcript
Positive5-5
The earnings call revealed strong financial performance with a 15% revenue increase and improved gross margins. Despite the absence of strategic initiatives and operational updates, the positive financial metrics and increased EPS indicate a healthy business outlook. The lack of negative sentiment in the Q&A further supports a positive stock price movement prediction.
inTEST Corporation (INTT) Q4 2025 Earnings Call Transcript
Positive2-27
The earnings call reveals strong financial performance, with record high revenue, improved gross margins, and debt reduction. The Q&A highlights cautious optimism, with growth expected in automotive and life sciences. Despite modest semi recovery guidance, the company is well-positioned for future growth, supported by new product launches and market diversification. While management's conservative guidance may temper expectations, the overall sentiment is positive, suggesting a likely stock price increase of 2% to 8%.
inTEST Corporation (INTT) Q3 2025 Earnings Call Transcript
Unknown11-5
The earnings call reveals mixed signals: strong order growth in key sectors and successful diversification efforts are positive, but revenue and gross profit declines, limited market recovery visibility, and flat guidance despite resolved challenges are concerning. The Q&A section highlights management's confidence, yet lacks clarity on guidance adjustments. Market conditions remain weak, especially in the semi sector, and margin declines further temper optimism. Overall, the sentiment remains neutral as positive long-term fundamentals balance short-term uncertainties and financial performance issues.
inTEST Corporation (INTT) Q2 2025 Earnings Call Transcript
Unknown8-6
The earnings call shows mixed signals. Basic financial performance is weak due to net losses, but cost-saving measures and debt reduction are positive. Product development and market strategy are promising with growth in orders and geographic expansion plans. However, uncertainties in the semi business rebound and vague guidance impact sentiment. Shareholder returns are not mentioned, and the Q&A reveals some management evasiveness. Overall, the stock is likely to remain stable, with a neutral sentiment.
INTT Slides
INTT Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
